Cardiol Therapeutics Inc. (TSX:CRDL)
Canada flag Canada · Delayed Price · Currency is CAD
1.810
-0.060 (-3.21%)
May 15, 2026, 4:00 PM EST

Cardiol Therapeutics Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
27.6721.4230.5834.9359.4783.9
Cash & Short-Term Investments
27.6721.4230.5834.9359.4783.9
Cash Growth
18.81%-29.97%-12.46%-41.26%-29.12%498.20%
Accounts Receivable
-----0.07
Other Receivables
0.340.230.360.280.480.34
Receivables
0.340.230.360.280.480.41
Prepaid Expenses
3.251.860.730.941.492.83
Total Current Assets
31.2723.531.6736.1561.4487.14
Property, Plant & Equipment
0.140.120.20.340.30.36
Other Intangible Assets
---0.210.290.38
Total Assets
31.4123.6231.8636.762.0387.88
Accounts Payable
3.423.486.987.628.354.14
Accrued Expenses
---0.420.990.72
Current Portion of Leases
0.040.040.030.020.050.04
Other Current Liabilities
3.672.14-0.240.426.66
Total Current Liabilities
7.135.667.018.39.811.57
Long-Term Leases
0.080.090.130.160.020.07
Total Liabilities
7.25.747.148.459.8311.64
Common Stock
212.8201.87179.34148.52147.55142.92
Additional Paid-In Capital
32.4729.0824.6518.7915.5912.66
Retained Earnings
-223.89-213.07-179.25-142.58-114.45-83.52
Comprehensive Income & Other
2.82--3.523.524.18
Shareholders' Equity
24.217.8824.7328.2552.276.24
Total Liabilities & Equity
31.4123.6231.8636.762.0387.88
Total Debt
0.120.130.160.170.070.12
Net Cash (Debt)
27.5621.2930.4234.7659.483.78
Net Cash Growth
19.08%-30.01%-12.47%-41.48%-29.10%504.11%
Net Cash Per Share
0.290.240.430.540.951.94
Filing Date Shares Outstanding
108.99111.8782.6168.2764.161.93
Total Common Shares Outstanding
108.99100.2682.6165.3564.0461.92
Working Capital
24.1417.8524.6627.8651.6375.58
Book Value Per Share
0.220.180.300.430.821.23
Tangible Book Value
24.217.8824.7328.0451.9175.86
Tangible Book Value Per Share
0.220.180.300.430.811.23
Machinery
-0.410.390.420.350.28
Leasehold Improvements
-0.240.240.240.240.24
Source: S&P Global Market Intelligence. Standard template. Financial Sources.